-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Da/SAU5F6fDaJ/sk1HQHaNLBN8kTxA/kwZHd/3tYH8SX0Cfbgx81BV9gws7TMeXo
 HZVaIsDV0e4+bVswm0blUw==

<SEC-DOCUMENT>0000932440-08-000507.txt : 20080808
<SEC-HEADER>0000932440-08-000507.hdr.sgml : 20080808
<ACCEPTANCE-DATETIME>20080808171745
ACCESSION NUMBER:		0000932440-08-000507
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20080806
FILED AS OF DATE:		20080808
DATE AS OF CHANGE:		20080808

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AVANIR PHARMACEUTICALS
		CENTRAL INDEX KEY:			0000858803
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				330314804
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			0930

	BUSINESS ADDRESS:	
		STREET 1:		101 ENTERPRISE
		STREET 2:		SUITE 300
		CITY:			ALISO VIEJO
		STATE:			CA
		ZIP:			92656
		BUSINESS PHONE:		949-389-6700

	MAIL ADDRESS:	
		STREET 1:		101 ENTERPRISE
		STREET 2:		SUITE 300
		CITY:			ALISO VIEJO
		STATE:			CA
		ZIP:			92656

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LIDAK PHARMACEUTICALS
		DATE OF NAME CHANGE:	19920703

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			SCHREIBER ALAIN
		CENTRAL INDEX KEY:			0001225149

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15803
		FILM NUMBER:		081003473

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		6099193567

	MAIL ADDRESS:	
		STREET 1:		90 NASSAU STREET
		STREET 2:		5TH FLOOR
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08542

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Moorin Jay
		CENTRAL INDEX KEY:			0001033508
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15803
		FILM NUMBER:		081003474

	BUSINESS ADDRESS:	
		STREET 1:		C/O PROQUEST INVESTMENTS, L.P.
		STREET 2:		600 ALEXANDER PARK
		CITY:			SUITE 204
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		6099193567

	MAIL ADDRESS:	
		STREET 1:		C/O PROQUEST INVESTMENTS, L.P
		STREET 2:		90 NASSAU STREET, 5TH FLOOR
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08542

	FORMER NAME:	
		FORMER CONFORMED NAME:	MOORIN JAY
		DATE OF NAME CHANGE:	19970213
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>edgar.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0303</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2008-08-06</periodOfReport>

    <issuer>
        <issuerCik>0000858803</issuerCik>
        <issuerName>AVANIR PHARMACEUTICALS</issuerName>
        <issuerTradingSymbol>AVNR</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001033508</rptOwnerCik>
            <rptOwnerName>Moorin Jay</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O PROQUEST INVESTMENTS</rptOwnerStreet1>
            <rptOwnerStreet2>90 NASSAU STREET, 5TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>PRINCETON</rptOwnerCity>
            <rptOwnerState>NJ</rptOwnerState>
            <rptOwnerZipCode>08542-4520</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001225149</rptOwnerCik>
            <rptOwnerName>SCHREIBER ALAIN</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O PROQUEST INVESTMENTS</rptOwnerStreet1>
            <rptOwnerStreet2>90 NASSAU STREET, 5TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>PRINCETON</rptOwnerCity>
            <rptOwnerState>NJ</rptOwnerState>
            <rptOwnerZipCode>08542-4520</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Class A Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2008-08-06</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>P</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>400</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>.90</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>7820870</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See footnote</value>
                    <footnoteId id="F1"/>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Class A Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2008-08-07</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>P</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>91380</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>.98</value>
                    <footnoteId id="F3"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>7912250</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See footnote</value>
                    <footnoteId id="F2"/>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Warrants to Purchase Class A Common Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>1.43</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2008-04-04</value>
            </exerciseDate>
            <expirationDate>
                <value>2013-04-04</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Class A Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>2708849</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>2708849</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See footnote</value>
                    <footnoteId id="F4"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Of such shares: 133 are owned by ProQuest Investments III, L.P. (&quot;Investments III&quot;), of which ProQuest Associates III LLC (&quot;Associates III&quot;) is the general partner, and 267 are owned by ProQuest Investments IV, L.P. (&quot;Investments IV&quot;), of which ProQuest Associates IV LLC (&quot;Associates IV&quot;) is the general partner.  Jay Moorin and Alain Schreiber are managing members of Associates III and Associates IV.  Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of each Reporting Person's pecuniary interest in such securities.</footnote>
        <footnote id="F2">Of such shares: 30,460 are owned by Investments III, and 60,920 are owned by Investments IV.  Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of each Reporting Person's pecuniary interest in such securities.</footnote>
        <footnote id="F3">Constitutes the weighted average purchase price for multiple transactions reported on this line having prices per share ranging from $.96 to $.99.  The Reporting Persons will provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding each separate transaction.</footnote>
        <footnote id="F4">Of such warrants: 902,950 are owned by Investments III, and 1,805,899 are owned by Investments IV.  The warrants contain a limitation on exercise, which, in combination with an agreement between the Reporting Persons and Avanir Pharmaceuticals, prevent the Reporting Persons from exercising any warrants if, after giving effect to the exercise the Reporting Persons would in the aggregate beneficially own more than 9.99% of the outstanding shares of Class A Common Stock.  Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of each Reporting Person's pecuniary interest in such securities.</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>/s/ Pasquale De Angelis as Attorney-in-Fact</signatureName>
        <signatureDate>2008-08-08</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----